Sunday, April 27, 2014 12:40:22 PM
Yes you do...however, to be a proper whistle blower, I would think you would need more than an opinion to whistle blow anything. At the moment, you're only blowing...I'll go with, smoke.
I suggest start by explaining Eltoprazine... positive safety features vs adverse side effects... it has proven strong safety results, if I'm not mistaken is sorted out mostly in phase I clinical trial? What have you got to prove otherwise?
LymPro...yeah, we all get that there isn't a cure for AD. I won't even get into all the reasons why there is still reasons for a test... what have you got, besides your opinion that you can provide that can bring to light of another test farther advanced,higher sens and spec...anything? We are still waiting.
Manf, so you feel alpha Syn is MJFF's focus. Fine, very well, it might be... you think MJFF has "disavowed" MANF..., well, they clearly didn't provide MANF with another grant but they did say MANF merits more research. Perhaps a biomarker is needed before trophic factors will be given more attention? Before the cells become 80% dead? They did an entire CC on neurotrophic factors a few months back, surely their entire focus isn't just on Alpha Syn.
For the sake of your website and being a self proclaimed whistle blower you say you are, back it up with something...yes, I mean concrete links, answer the questions Warp and Zoom, especially, have asked you, and I suggest answering them in a direct sort of fashion!
I'd love to see a proper devil's advocate to AMBS pipeline and science but in my opinion you haven't taken that torch yet. Go ahead, take your time, write out your own Joboggi white paper for us to read. Take that role as a whistle blower, grab onto that torch, and save unfortunate investor's hard earned monies! Until then, opinions, including mine, mean nothing.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM